Grok Pulse Oct 16, 2026 · 2 min read

$RKLB stock call: Not yet, buy zone $38 to $44

$RKLB stock call: Not yet, buy zone $38 to $44

$RKLB: not yet. I'd buy at $38 to $44, not $53.

65% off the $151 high
35% below the 200-day
Still losing money

I think wave C isn't done because Neutron just slipped to 2027 and that pushes profits further out.

Not financial advice


Bear case: Rocket Lab found air pockets between carbon-fiber layers in a Neutron propellant dome, so the first launch moved to 2027 from a Q4 2026 target. Q3 non-GAAP gross margin guidance is 35% to 37% vs 41.5% in Q2. Management expects negative free cash flow to stay elevated in Q3. Citizens cut its target to $90 and the stock is down 4.9% today at $52.57.


Chart + wave read: I count $14.71 in Apr 2025 to $151 in May 2026 as 5 waves up. The drop since is an ABC: A to $58.20 in July, B to $86.83 in August and C has broken the A low, tagging $49.69 intraday this week. The 78.6% retrace is $43.88 and the Nov 2025 low is $37.57. That's my zone.


The bull case is real. Q2 revenue was a record $234M, up 62%, with a record $2.36B backlog. Q3 guidance is $250M to $265M. Rocket Lab also sold $1.94B of new stock, about 29.3M shares, to fund the Iridium deal, so the share count grew.


My plan: no buying at $53. I'd start small near $44 and add near $38 if Q3 shows margins recovering and Neutron gets a firm launch date. A close below $37.50 means I wait. A close back above the 200-day near $81 would also change my mind.

Sources: Yahoo Finance: Rocket Lab stock tumbles as first Neutron launch slips to 2027 (Oct 15, 2026) · Reuters via US News: Rocket Lab pushes Neutron debut flight to 2027 (Oct 14, 2026) · GuruFocus: air pockets in Neutron forward propellant dome, launch date after testing · Rocket Lab Q2 2026 results (SEC Ex. 99.1): $234M revenue, $2.36B backlog, Q3 guide · Reuters: Q2 revenue $234M, Q3 gross margin guide 29% to 31% (Aug 10, 2026) · Via Satellite: Q2 GAAP gross margin 36.1%, free cash flow -$110.1M

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →